2m 2m 2m 2m 2m 2m 2m
HARVARD BIO (HBIO)
NASDAQ
$5.93-$0.13 (-2.13%)
Price as of Jun 23, 2026 6:28 PM EDT- $27.3MMarket Cap
- 17.87%1-Year Change
- Medical Instruments & SuppliesIndustry
HARVARD BIO (HBIO)
$5.93-$0.13 (-2.13%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 86.5M -8.06% | 94.1M -16.14% | 112.3M -0.96% | 113.3M -4.68% | |
Cost of Revenue | 36.6M -6.93% | 39.4M -14.75% | 46.2M -12.07% | 52.5M +2.47% | |
Gross Profit | 49.9M -8.87% | 54.8M -17.11% | 66.1M +8.64% | 60.8M -10.10% | |
Sales and Marketing Expense | 19.2M -13.49% | 22.2M -7.86% | 24.1M -3.73% | 25.0M +1.62% | |
Research and Development Expense | -8.8M -15.19% | -10.4M -11.54% | -11.8M -4.58% | -12.3M +14.17% | |
Depreciation and Amortization Expense | 1.7M +0.93% | 1.7M +17.24% | 1.5M +1.38% | 1.5M -18.42% | |
Total Operating Expenses | 98.5M +61.52% | 61.0M -4.99% | 64.2M -5.28% | 67.8M +3.30% | |
Operating Profit | -48.6M +682.16% | -6.2M -427.93% | 1.9M +127.32% | -6.9M -435.58% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | -4.9M +53.23% | -3.2M -10.64% | -3.6M +40.93% | -2.5M +65.45% | |
Interest Income and Expense and Net | -4.9M +53.23% | -3.2M -10.64% | -3.6M +40.93% | -2.5M +65.45% | |
Total Nonoperating Income and Expense | -8.8M +61.46% | -5.5M +22.56% | -4.5M +98.13% | -2.2M +1.81% | |
Income before Taxes | -57.4M +391.95% | -11.7M +356.38% | -2.6M -72.15% | -9.2M +6,456.43% | |
Income Taxes | -686,000 -192.70% | 740,000 -13.85% | 859,000 +154.90% | 337,000 +127.70% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -56.7M +357.07% | -12.4M +263.25% | -3.4M -64.11% | -9.5M +3,204.17% | |
Net Income from Continuing Operations Applicable to Common | -57.4M +391.95% | -11.7M +356.38% | -2.6M -72.15% | -9.2M +6,456.43% | |
Basic EPS and Net Income | -1.28 +357.14% | -0.28 +250.00% | -0.08 -65.22% | -0.23 +2,200.00% | |
Diluted EPS and Net Income | -1.28 +357.14% | -0.28 +250.00% | -0.08 -65.22% | -0.23 +2,200.00% | |
Basic Weighted Average Shares | 44.4M +1.96% | 43.5M +2.64% | 42.4M +2.43% | 41.4M +2.65% | |
Diluted Weighted Average Shares | 44.4M +1.96% | 43.5M +2.64% | 42.4M +2.43% | 41.4M +2.65% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 8.6M +109.69% | 4.1M -4.09% | 4.3M -4.99% | 4.5M -42.36% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 8.6M +109.69% | 4.1M -4.09% | 4.3M -4.99% | 4.5M -42.36% | |
Total Current Assets | 48.2M +6.89% | 45.1M -8.00% | 49.0M -4.08% | 51.1M -16.98% | |
Accumulated Depreciation | 18.1M +14.51% | 15.8M +9.98% | 14.4M -3.11% | 14.8M +2.75% | |
Property and Plant and Equipment and Net | 4.8M -6.25% | 5.1M +28.26% | 4.0M +18.27% | 3.4M -1.43% | |
Total Long-Term Assets | 2.7M -5.08% | 2.8M -56.23% | 6.5M -16.80% | 7.8M +44.74% | |
Total Assets | 80.1M -36.77% | 126.6M -7.81% | 137.4M -5.50% | 145.4M -10.46% | |
Income Taxes Payable | 317,000 -55.35% | 710,000 -8.51% | 776,000 +31.53% | 590,000 -62.13% | |
Total Short-Term Debt | 0 -100.00% | 37.0M +530.76% | 5.9M +53.74% | 3.8M +17.81% | |
Total Current Liabilities | 22.0M -60.04% | 55.0M +107.06% | 26.5M +14.16% | 23.2M -8.16% | |
Total Long-Term Debt | 35.9M N/A | 0 -100.00% | 30.7M -28.62% | 43.0M -4.62% | |
Total Long-Term Liabilities | 1.3M +4.22% | 1.3M -14.97% | 1.5M +46.72% | 1.0M +107.00% | |
Total Liabilities | 66.3M +4.79% | 63.3M -1.54% | 64.3M -12.10% | 73.1M -7.35% | |
Retained Earnings | -214.7M +35.88% | -158.0M +8.52% | -145.6M +2.40% | -142.2M +7.17% | |
Total Stockholders Equity | 13.7M -78.32% | 63.3M -13.32% | 73.1M +1.18% | 72.2M -13.41% | |
Total Shares Outstanding | -39.7M -190.09% | 44.1M +1.57% | 43.4M +3.12% | 42.1M +2.28% | |
Cash Flow | |||||
Cash from Operating Activities | 6.7M +367.29% | 1.4M -89.73% | 14.0M +1,117.71% | 1.2M -8.72% | |
Capital Expenditures | 1.3M -52.42% | 2.6M +47.87% | 1.8M +12.45% | 1.6M +33.05% | |
Cash from Investing Activities | -1.9M +38.62% | -1.3M -25.29% | -1.8M +13.14% | -1.6M +18.22% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | -1.3M +885.50% | -131,000 -98.92% | -12.1M +327.71% | -2.8M +1,025.79% | |
Financials Ratio | |||||
Gross Margin | 57.67% -0.88% | 58.18% -1.16% | 58.86% +9.69% | 53.66% -5.68% | |
Operating Margin | -56.13% +750.70% | -6.60% -491.04% | 1.69% +127.58% | -6.12% -452.07% | |
Return on Assets | -54.86% +483.76% | -9.40% +289.00% | -2.42% -60.94% | -6.19% +3,321.02% | |
Return on Equity | -147.13% +708.98% | -18.19% +286.90% | -4.70% -61.56% | -12.23% +3,299.03% | |
Revenue Growth | -8.06% -50.07% | -16.14% +1,585.79% | -0.96% -79.56% | -4.68% -128.46% | |
Current Ratio | 2.20 +167.51% | 0.82 -55.57% | 1.85 -15.98% | 2.20 -9.60% | |
Cash Ratio | 0.39 +425.17% | 0.07 -53.72% | 0.16 -16.76% | 0.19 -37.23% | |
Debt-to-Equity Ratio | 2.61 +347.61% | 0.58 +16.61% | 0.50 -22.83% | 0.65 +11.89% | |
Debt-to-Assets Ratio | 0.45 +53.53% | 0.29 +9.62% | 0.27 -17.35% | 0.32 +8.20% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow